decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / 220.6.7
Subscribe or sign in to view the full article.
Article Overview
This article summarizes Medicare’s national coverage policy for FDG PET in head and neck cancers. It explains the general coverage scope, the time-based policy updates, the circumstances addressed for diagnosis, staging, restaging, and monitoring response to treatment, and the documentation responsibilities tied to the policy. It is relevant to coders, billing staff, compliance teams, and clinicians working with oncology imaging and Medicare rules.
Why This Topic Matters
Coverage for advanced imaging in oncology depends on specific Medicare policy language and effective dates. Understanding this article helps billing and compliance teams determine whether the service falls within the covered policy framework and what documentation the referring physician must maintain.
Article Sections
-
FDG PET for Head and Neck Cancers
Introduces the Medicare coverage topic, the affected cancer site category, and the overall policy context for the manual section.
-
Coverage History and Limitations
Summarizes the effective-date changes and the limits on the policy over time, including references to related manual coverage provisions.
-
Requirements
Outlines the broad circumstances addressed by the policy and the documentation expectation placed on the referring physician.
What You Will Learn
- The Medicare coverage scope for FDG PET in head and neck cancer cases
- How the policy is organized around diagnosis, staging, restaging, and treatment monitoring
- Which policy changes are tied to effective dates and related manual references
- What documentation is expected to support the service in the medical record
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Compliance professionals
- Oncology clinicians
- Radiology and nuclear medicine staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com